ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Baruch D. Kuppermann, MD, PhD, speaks about some products in development that share a common theme.
Risuteganib (Allegro Ophthalmics) and elamipretide (Stealth BioTherapeutics) are mitochondrial membrane stabilizers, both seemingly effective for improving vision in dry age-related macular degeneration or even early-stage geographic atrophy. Famzeretcel (jCyte) is a novel stem cell therapy for retinitis pigmentosa.
“What they all have in common is that these are conditions with damaged retinas, and these